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Sirs, 
Tolosa-Hunt syndrome (THS) is characterized by painful ophthalmoplegia due to an 
idiopathic chronic granulomatous inflammation of the cavernous sinus.[9]  THS 
usually improves with corticosteroids, however, in cases showing an insufficient effect 
of corticosteroid therapy or side effects, alternative therapies such as 
immunosuppressive agents[3] or focal radiation therapy have been reported.[2,5-7]  
We describe a patient with THS who was successfully treated with radiation 
monotherapy. 
     A 36-year-old man with chronic hepatitis B and impaired glucose tolerance since 
age 30 developed acute left orbital pain and double vision at the end of July 2006.  
Neurologic examination on 3 August 2006 demonstrated only mild restriction of 
abduction of the left eye.  Magnetic resonance imaging (MRI) of the brain showed no 
abnormality including the cavernous sinus region at that time.  His illness progressed 
rapidly and he was admitted to our hospital on 14 August 2006. 
     On admission, body temperature and blood pressure were normal.  Neurologic 
examination demonstrated almost complete ophthalmoplegia in all directions and 
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blepharoptosis without pupil abnormality on the left.  Spontaneous left ophthalmic 
pain was also reported.  There were no ophthalmic symptoms on the right and there 
were no symptoms of lower cranial nerves on both sides.  Urinalysis and routine 
hematological examination were normal.  Blood chemistry examination demonstrated 
mild elevation of asparatate aminotransferase (60 IU/L; normal range 11-34 IU/L), 
alanine aminotransferase (151 IU/L; normal range 6-39 IU/L) and glycohemoglobin 
A1c (6.1%; normal range 4.3-5.8 %).  Surface antigen and core antibody of hepatitis B 
virus were positive.  The following immunological and inflammatory investigations 
were normal or negative; antinuclear antibody, cytoplasmic and perinuclear 
antineutrophil cytoplasmic antibody, angiotensin converting enzyme level and β-D 
glucan.  Chest radiography and Gallium scintigraphy of the whole body showed no 
abnormality suggestive of systemic inflammatory disease.  Cerebrospinal fluid 
examinations were normal including cytology and culture for bacteria and mycobacteria.  
Brain MRI showed abnormal soft tissue enhanced with gadolinium within the left 
cavernous sinus (Figure). 
     Based on a diagnosis of THS, we first considered corticosteroid therapy for THS 
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with simultaneous antiviral therapy for hepatitis; however, the patient refused 
corticosteroid therapy because of the possible exacerbation of hepatitis.  One week 
after admission, the left pupil was dilated and light response was diminished, indicating 
progression of THS.  Thereafter, the patient received a total of 30 Gy in 15 fractions 
focused on the left cavernous sinus by three-dimensional conformal radiotherapy 
(3D-CRT). 
     Left blepharoptosis and ophthalmoplegia gradually improved within two weeks 
after the initiation of radiation therapy; blepharoptosis had almost completely 
disappeared by the middle of October 2006.  Ophthalmoplegia also completely 
recovered by the beginning of January 2007.  The illness remained in remission 
without any side effects during the observation period of one year. 
    However, the response to corticosteroid therapy could not be evaluated due to 
chronic hepatitis B, our patient fulfilled the remaining diagnostic criteria of THS by the 
International Headache Society,[4] and was successfully treated with radiation 
monotherapy.   
     Previous reports for radiation therapy in THS are shown in the Table.[2,5-7]  All 
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four reported patients had received corticosteroid as an initial treatment, and radiation 
therapy was added because corticosteroid therapy showed insufficient effects (steroid 
dependence or steroid resistance) or severe side effects.  It should be noted that our 
patient received only radiation therapy resulting in improvement of THS.  To our 
knowledge, there has not been any previous report of radiation monotherapy for THS. 
     There has not been any consensus regarding the dose of radiation for THS.  
However, low dose radiation seems to be sufficiently effective as shown in the Table.  
The response of our patient demonstrated that low dose radiation monotherapy is 
effective in THS. 
     Additionally our patient and previously described patients who had received low 
dose radiation therapy for THS had no adverse effects related to the therapy during 
observation period (maximum 8 years).  In case of exposure of the cavernous sinus to 
radiation, adverse effect on visual pathway and cranial nerves within the cavernous 
sinus should be concerned,[8] however, low dose irradiation to cavernous sinus by 
3D-CRT method may be safe, referring to the neuronal tissue tolerance to irradiation 
(e.g. tolerance dose at the 5% complication rate within 5 years from treatment (TD 5/5) 
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for optic nerve and chiasma is 50 Gy).[1]  Radiation monotherapy would be a useful 
and safe therapeutic option when it is difficult or contraindicated to use corticosteroids 
due to complications.
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Figure legend 
Axial sections of T1-weighted images before (A) and after enhancement with 
gadolinium (B).  The soft tissue within the left cavernous sinus with intermediate 
signal intensity shows obvious gadolinium enhancement (arrow heads).
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Table. Patients with Tolosa-Hunt syndrome treated with radiation therapy 
Patient 
No. 













Interval between initiation of 
radiation and improvement 








1. Nasr YG et al. 
(1987) [7] 
49 female yes no 50 not available yes not available no not available 2 years 
2. Larner JM et al. 
(1991) [5] 
50 male yes no 20 5.5 months yes not available no not available 11 months 
3. Mormont E et al. 
(2000) [6] 
32 female yes yes (azathioprine) 30 22 days yes 15 days no no 3 years 
4. Foubert-Samier A et al. 
(2005) [2] 
41 male yes no 20 not available yes not available no no 8 years 
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